Physician profile
Mandy Binning
NPI 1104001791
$383.39
in general payments reported to CMS, 2019-2025
13 companies · $64.14 in 2025
The $64.14 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.04 · 2021: $37.26 · 2022: $32.71 · 2023: $54.87 · 2024: $168 · 2025: $64.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $141.55 | 2024 | Cerepak Uniform |
| Route 92 Medical, INC. | $72.00 | 2024-2025 | 8f Base Camp Sheath System |
| Teva Pharmaceuticals USA, INC. | $23.17 | 2023 | Austedo |
| Biohaven Pharmaceuticals, INC. | $22.93 | 2021 | |
| Impel Pharmaceuticals LLC | $18.96 | 2025 | Trudhesa |
| Abbvie INC. | $17.71 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $16.88 | 2023 | Andexxa |
| Penumbra, INC. | $15.00 | 2022 | |
| Terumo Medical Corporation | $14.87 | 2019 | |
| Pfizer INC. | $14.82 | 2023 | |
| Silk Road Medical, INC. | $14.33 | 2021 | |
| Integra Lifesciences Corporation | $11.17 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandy Binning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.